Filing Details
- Accession Number:
- 0001140361-20-026650
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-25 19:42:10
- Reporting Period:
- 2020-11-19
- Accepted Time:
- 2020-11-25 19:42:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1228627 | Ocuphire Pharma Inc. | OCUP | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1212162 | R Alan Meyer | C/O Ocuphire Pharma, Inc. 37000 Grand River Ave, Suite 120 Farmington Hills MI 48335 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-11-19 | 1,771 | $0.00 | 487,029 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Warrant (right to buy) | Acquisiton | 2020-11-19 | 2,679 | $0.00 | 2,679 | $4.48 |
| Common Stock | Series B Warrant (right to buy) | Acquisiton | 2020-11-19 | 315 | $0.00 | 315 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,679 | 2020-11-19 | 2025-11-19 | No | 4 | P | Direct |
| 315 | 2020-11-19 | 2022-01-28 | No | 4 | P | Direct |
Footnotes
- The Reporting Person purchased shares, Series A Warrants and Series B Warrants as part of a private placement for an aggregate price of $10,000.
- Subject to adjustment based on certain price reset provisions.
Billionaire Hedge Funds
